Jasper Therapeutics (JSPR) EBITDA (2021 - 2025)
Jasper Therapeutics (JSPR) recorded EBITDA of -$15.51 million in Q4 2025, compared with -$25.01 million a year earlier.
Powered by 
Analysis
Jasper Therapeutics (JSPR) EBITDA (2021 - 2025) Analysis & Trends
For FY2025, Jasper Therapeutics reported EBITDA of -$82.78 million.
- Across earlier years, EBITDA came in at -$74.84 million in FY2024, -$67.75 million in FY2023, -$50.2 million in FY2022 and -$36.43 million in FY2021.
- The Q4 2025 figure is the highest quarterly EBITDA since Q1 2024.
- Per Business Quant, the preceding three quarters came in at -$18.94 million (Q3 2025), -$26.82 million (Q2 2025) and -$21.52 million (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 12.29 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 9.10 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 8.33 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 999.00 Mn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 5.09 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 4.63 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | -9.70 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 5.89 Bn |
| 10 | Jasper Therapeutics | 14.47 Mn | -111.94 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -15.51 Mn |
| Sep 30, 2025 | -18.94 Mn |
| Jun 30, 2025 | -26.82 Mn |
| Mar 31, 2025 | -21.52 Mn |
| Dec 31, 2024 | -25.01 Mn |
| Sep 30, 2024 | -19.39 Mn |
| Jun 30, 2024 | -15.69 Mn |
| Mar 31, 2024 | -14.78 Mn |
| Dec 31, 2023 | -17.44 Mn |
| Sep 30, 2023 | -19.06 Mn |
| Jun 30, 2023 | -17.53 Mn |
| Mar 31, 2023 | -13.67 Mn |
| Dec 31, 2022 | -13.45 Mn |
| Sep 30, 2022 | -12.41 Mn |
| Jun 30, 2022 | -11.76 Mn |
| Mar 31, 2022 | -12.56 Mn |
| Dec 31, 2021 | -11.88 Mn |
| Sep 30, 2021 | -9.98 Mn |
| Jun 30, 2021 | -8.32 Mn |
| Mar 31, 2021 | -6.15 Mn |
API Access
Jasper Therapeutics EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=JSPR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "JSPR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=JSPR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();